Work

Systemic proteomic and metabolomic signature of the SGLT2 inhibitor dapagliflozin

Year: 2022

Type: article

Source: The FASEB Journal

DOI: 10.1096/fasebj.2022.36.s1.r4450

Authors: Anja Billing, Young‐Chul Kim, Volker Vallon, Markus Rinschen

Institutions: Aarhus University, University of California San Diego

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Novo Nordisk Fonden, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1535250469, G7956689339, Glomerular and Tubular Function in the Diabetic Kidney

OpenAlex ID: W4225368729

FWCI: 0.185

Cites:

Cited by: 1

Related to: 10